Pacific Capital Partners Ltd Has $399,000 Stock Position in Prestige Consumer Healthcare Inc. $PBH

Key Points

• Pacific Capital Partners Ltd has reduced its stake in Prestige Consumer Healthcare (NYSE:PBH) by 60%, holding 5,000 shares valued at $399,000 after selling 7,500 shares during the second quarter.
• Several hedge funds increased their positions in Prestige Consumer Healthcare, with Jane Street Group LLC boosting its holdings by 204% to own 104,802 shares worth $9,010,000.
• Analysts have varied opinions on the stock, with Canaccord Genuity lowering its price target from $105 to $100, while Zacks Research changed its rating from "hold" to "strong sell."

Pacific Capital Partners Ltd reduced its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 60.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,000 shares of the company's stock after selling 7,500 shares during the quarter. Pacific Capital Partners Ltd's holdings in Prestige Consumer Healthcare were worth $399,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Voya Investment Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 19.5% during the first quarter. Voya Investment Management LLC now owns 41,717 shares of the company's stock valued at $3,586,000 after buying an additional 6,798 shares during the last quarter. Strs Ohio acquired a new position in shares of Prestige Consumer Healthcare during the first quarter valued at about $318,000. Geneos Wealth Management Inc. boosted its holdings in Prestige Consumer Healthcare by 92.8% during the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company's stock worth $48,000 after purchasing an additional 269 shares during the last quarter. Intech Investment Management LLC boosted its holdings in Prestige Consumer Healthcare by 18.9% during the first quarter. Intech Investment Management LLC now owns 27,307 shares of the company's stock worth $2,348,000 after purchasing an additional 4,343 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in Prestige Consumer Healthcare by 204.0% during the first quarter. Jane Street Group LLC now owns 104,802 shares of the company's stock worth $9,010,000 after purchasing an additional 70,330 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PBH has been the topic of several analyst reports. Canaccord Genuity Group cut their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Zacks Research cut shares of Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a report on Thursday, September 4th. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock opened at $63.31 on Friday. The firm has a market cap of $3.12 billion, a price-to-earnings ratio of 14.86, a P/E/G ratio of 2.06 and a beta of 0.46. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare Inc. has a 52 week low of $62.95 and a 52 week high of $90.04. The firm's 50-day simple moving average is $70.53 and its two-hundred day simple moving average is $79.18.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business's revenue was down 6.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.